Ajani, Jaffer A <br/><br/>
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.  [electronic resource] 

 -  Journal of the National Comprehensive Cancer Network : JNCCN  07 2019 
 - 855-883 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1540-1413 
<br/><br/><label>Standard No.: </label>10.6004/jnccn.2019.0033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Chemoradiotherapy, Adjuvant<br/>Combined Modality Therapy<br/>Esophageal Neoplasms--classification<br/>Esophagogastric Junction--pathology<br/>Guidelines as Topic<br/>Humans<br/>Medical Oncology<br/>Ramucirumab